📰 Sofinnova Partners News
Page 20 - Sofinnova Partners News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sofinnova Partners. Real-time updates on events, politics, business and more.
September 2, 2022
LONDON, Sept. 2, 2022 /PRNewswire/ -- Dechert advised Abivax on its successful €49.2 million financing with top U.S. and European biotech specialist investors. The financing was underwritten
August 4, 2022
New Investment from Forbion and Sofinnova Partners MANCHESTER, England, Aug. 4, 2022 /PRNewswire/ -- F2G Ltd, a clinical-stage biopharmaceutical company focused on the discovery and development
August 4, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
August 4, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
August 4, 2022
Forbion Co-leads $70 Million Financing of F2G to Advance Development and Commercialization of New Antifungal Agent Olorofim Naarden, The Netherlands, 4...
August 4, 2022
The top five medical devices industry cross border venture financing deals in Europe in Q2 2022 - GlobalData Deals Database
July 20, 2022
DGAP-News: iOmx Therapeutics AG / Key word(s): PersonneliOmx Therapeutics Announces the Appointment of Three New Supervisory Board Members 20.07.2022 / 09:30 The issuer is solely responsible for the content of this announcement.iOmx Therapeutics Announces the Appointment of Three New Supervisory Board MembersMartins...
July 14, 2022
Biosyntia, founded by Morten Sommer, Hans Genee and Andreas Hougaard Laustsen as a spin-out from the Centre for Biosustainability, at the Technical University
July 13, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
July 12, 2022
/PRNewswire/ -- GlycoEra AG announced today key appointments of biotech industry leaders to its Board of Directors, including Georges Gemayel, Ph.D., as Chair,...